Mavacamten in Obstructive Hypertrophic Cardiomyopathy Patients Referred for Septal Reduction: Health Status Analysis Through Week 56 in VALOR-HCM Trial.
Document Type
Article
Publication Date
9-10-2024
Publication Title
Journal of the American College of Cardiology
Volume
84
Issue
11
First Page
1041
Last Page
1045
Recommended Citation
Desai MY, Owens A, Wolski K, Geske JB, Saberi S, Wang A, et al [Fermin D] Mavacamten in obstructive hypertrophic cardiomyopathy patients referred for septal reduction: health status analysis through week 56 in valor-hcm trial. J Am Coll Cardiol. 2024 Sep 10;84(11):1041-1045. doi: 10.1016/j.jacc.2024.06.025. PMID: 39232631
DOI
10.1016/j.jacc.2024.06.025
ISSN
1558-3597
PubMed ID
39232631
COinS